What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials

What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials

BackgroundHuman papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) has increased in incidence in recent decades. With higher cure rates in younger populations, long-term survivors may live with acute- and long-term toxicity, leading to increased interest in de-escalation t...

Full description

Bibliographic Details
Main Authors: Emma A. Mensour, Shintha Alam, Seliya Mawani, Houda Bahig, Pencilla Lang, Anthony Nichols, David A. Palma, Katie Jasper
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
radiotherapy
chemoradiotherapy
human papillomavirus
oropharyngeal cancer
treatment de-escalation
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1067321/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1067321/full

Similar Items